Elo Mutual Pension Insurance Co Decreases Position in Bath & Body Works, Inc. (NYSE:BBWI)

Elo Mutual Pension Insurance Co lessened its position in Bath & Body Works, Inc. (NYSE:BBWI) by 2.9% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 14,839 shares of the company’s stock after selling 449 shares during the period. Elo Mutual Pension Insurance Co’s holdings in Bath & Body Works were worth $579,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. TD Asset Management Inc boosted its stake in Bath & Body Works by 3.7% during the 4th quarter. TD Asset Management Inc now owns 976,278 shares of the company’s stock valued at $42,136,000 after purchasing an additional 35,261 shares during the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. boosted its position in shares of Bath & Body Works by 28.1% during the first quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 258,617 shares of the company’s stock valued at $12,936,000 after buying an additional 56,764 shares during the last quarter. Russell Investments Group Ltd. increased its holdings in Bath & Body Works by 46.9% in the 1st quarter. Russell Investments Group Ltd. now owns 131,605 shares of the company’s stock worth $6,572,000 after buying an additional 41,995 shares in the last quarter. Vanguard Group Inc. raised its position in Bath & Body Works by 4.2% in the 1st quarter. Vanguard Group Inc. now owns 27,398,192 shares of the company’s stock worth $1,370,458,000 after buying an additional 1,102,124 shares during the last quarter. Finally, SG Americas Securities LLC lifted its stake in Bath & Body Works by 968.1% during the 1st quarter. SG Americas Securities LLC now owns 190,758 shares of the company’s stock valued at $9,542,000 after acquiring an additional 172,898 shares during the period. Hedge funds and other institutional investors own 95.14% of the company’s stock.

Bath & Body Works Trading Down 2.1 %

BBWI opened at $29.28 on Friday. The stock has a 50-day moving average of $32.58 and a 200 day moving average of $40.79. Bath & Body Works, Inc. has a 12 month low of $26.20 and a 12 month high of $52.99. The firm has a market cap of $6.54 billion, a P/E ratio of 7.55, a P/E/G ratio of 0.86 and a beta of 1.77.

Bath & Body Works (NYSE:BBWI) last posted its quarterly earnings data on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, topping the consensus estimate of $0.35 by $0.02. Bath & Body Works had a net margin of 12.69% and a negative return on equity of 41.94%. The company had revenue of $1.53 billion during the quarter, compared to analyst estimates of $1.54 billion. On average, research analysts forecast that Bath & Body Works, Inc. will post 3.18 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, September 6th. Stockholders of record on Friday, August 23rd were paid a dividend of $0.20 per share. The ex-dividend date was Friday, August 23rd. This represents a $0.80 dividend on an annualized basis and a dividend yield of 2.73%. Bath & Body Works’s dividend payout ratio is 20.62%.

Wall Street Analyst Weigh In

A number of equities research analysts have commented on BBWI shares. Deutsche Bank Aktiengesellschaft cut their target price on shares of Bath & Body Works from $57.00 to $54.00 and set a “buy” rating for the company in a research report on Monday, August 26th. Piper Sandler cut their price objective on Bath & Body Works from $47.00 to $39.00 and set a “neutral” rating for the company in a report on Thursday, July 11th. Wells Fargo & Company lowered their target price on Bath & Body Works from $48.00 to $40.00 and set an “equal weight” rating on the stock in a report on Wednesday, July 24th. Evercore ISI cut their price target on Bath & Body Works from $45.00 to $35.00 and set an “in-line” rating for the company in a research note on Wednesday, August 28th. Finally, Telsey Advisory Group reiterated an “outperform” rating and issued a $53.00 price objective on shares of Bath & Body Works in a research note on Wednesday, August 28th. Eight analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. According to data from MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $43.00.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.